Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    12181401 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy
Condition: Gastrointestinal Stromal Tumor
Intervention:
2 Completed
Has Results
Rechallenge of Imatinib in GIST Having no Effective Treatment
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Imatinib;   Drug: Placebo
3 Recruiting Matching Patients With Hematologic Malignancy to Adequate Clinical Trials
Condition: Hematologic Malignancies
Interventions: Other: Matching on the basis of molecular analysis;   Other: Matching on the basis of physician's choice
4 Recruiting Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors;   Resected Gastrointestinal Stromal Tumors;   Non-metastatic;   High Risk of Recurrence;   KIT Gene Mutation
Intervention: Drug: Imatinib maintenance
5 Recruiting Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Condition: Neoplasms
Intervention: Genetic: Blood and tumor samples
6 Unknown  Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib mesylate

Study has passed its completion date and status has not been verified in more than two years.